Gregory Sargen

Gregory Sargen has served on Protara’s board of directors since November 2019 and is a licensed Certified Public Accountant (inactive) with extensive experience working within the healthcare industry. Mr. Sargen served as Chief Financial Officer and Executive Vice President, Corporate Development and Strategy of Cambrex Corporation from January 2017 until January 2020, following the December 2019 acquisition of Cambrex by a private equity company. Previously, he served as Executive Vice President and Chief Financial Officer at Expanets, Inc., and Vice President of Finance – Chemicals Manufacturing Division at Fisher Scientific International Inc. Prior to that, Mr. Sargen held senior positions with Merck & Co., Inc., Heat and Control, Inc. and Deloitte & Touche LLP. His board experience includes his current role as a director of Avid Bioservices, Inc., Umoja Biopharma, Inc. and Kindeva Drug Delivery, L.P. Mr. Sargen holds a B.A. in Accounting from Pennsylvania State University and an M.B.A. in Finance from The Wharton School of the University of Pennsylvania.